Biopharma Business

Drug Delivery

Anti-Pancreatic Cancer Drug In Research Focus

    Anti-Pancreatic Cancer Drug In Research Focus

Intriguing antitumor activity is found in a very promising class of natural compounds: cyclic depsipeptides, which have a challenging structure that makes their investigation difficult. Now, Chinese scientists have established

Read Full Article

FDA collaboration uses Organs-on-Chips to improve drug development

    FDA collaboration uses Organs-on-Chips to improve drug development

CN Bio Innovations Limited has announced today that it has entered into a Research Collaboration Agreement with the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research

Read Full Article

Tarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer

    Tarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer

EGFR is a common genetic target in lung cancer, but not all EGFR mutations are created equal. Patients with a type of EGFR anomaly called an “EGFR exon 20 insertion”

Read Full Article

Anticoagulant drugs appear to reduce the risk of stroke in patients with AF

    Anticoagulant drugs appear to reduce the risk of stroke in patients with AF

Blood-thinning drugs not only reduce the risk of stroke in patients with atrial fibrillation (AF) but are also associated with a significant reduction in the risk of dementia, according to

Read Full Article

Biogen takes up option to co-develop Eisai AD drug

    Biogen takes up option to co-develop Eisai AD drug

Biogen and Eisai have expanded their existing collaboration agreement to develop and commercialise investigational therapies for Alzheimer’s Disease. Eisai has taken up its option to co-develop and co-promote aducanumab, Biogen’s

Read Full Article

Ketamine may help treat migraine pain unresponsive to other therapies

    Ketamine may help treat migraine pain unresponsive to other therapies

Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain in patients who have not been helped by other treatments. The study

Read Full Article

FDA accepts regulatory submission for Lynparza in metastatic breast cancer

    FDA accepts regulatory submission for Lynparza in metastatic breast cancer

Lynparza has the potential to offer a new treatment option for patients with metastatic breast cancer. AstraZeneca and Merck & Co., have announced that the US Food and Drug Administration

Read Full Article

Janssen announces FDA approval of Stelara for plaque psoriasis

    Janssen announces FDA approval of Stelara for plaque psoriasis

The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis. Janssen Biotech, Inc., has announced that the U.S. Food and Drug Administration

Read Full Article

Titan gets under the skin of Parkinson’s with first patient administered with ropinirole implant

    Titan gets under the skin of Parkinson’s with first patient administered with ropinirole implant

Titan Pharmaceuticals has announced that the first patient has been treated in a Phase I/II trial of its ropinirole subdermal implant for the treatment of the signs and symptoms of

Read Full Article

NIH launches $215m partnership for cancer immunotherapy strategies

    NIH launches $215m partnership for cancer immunotherapy strategies

The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot… The National Institutes of Health (NIH)

Read Full Article

FDA Gives Positive Review Of Aerie’s Experimental Glaucoma Drug

    FDA Gives Positive Review Of Aerie’s Experimental Glaucoma Drug

A study by the U.S. Food and Drug Administration has backed up Aerie Pharmaceutical’s evidence that its experimental drug is effective in treating glaucoma. According to Reuters, the results were from a

Read Full Article

Gel Developed To Fight Rheumatoid Arthritis

    Gel Developed To Fight Rheumatoid Arthritis

IBS scientists at the Center for Self-Assembly and Complexity, within the Institute for Basic Science (IBS), invented a hydrogel to fight rheumatoid arthritis and other diseases. Published in Advanced Materials, this

Read Full Article

Researchers Help Develop New Antifungal Drug

    Researchers Help Develop New Antifungal Drug

University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.

Read Full Article

FDA Acts to Eencourage Generic Competition for Complex Drugs

    FDA Acts to Eencourage Generic Competition for Complex Drugs

The U.S. Food and Drug Administration is opening a new front in its efforts to reduce high drug prices by encouraging development of generic versions of hard-to-make medicines. Complex drugs

Read Full Article

Start-Up Company Receives $10.8M to Develop Cocaine & Nicotine Addiction Drug

    Start-Up Company Receives $10.8M to Develop Cocaine & Nicotine Addiction Drug

Camino Pharma, LLC, a new start-up company focusing on finding cures for cancer and brain disorders, announced  that its Co-founder and Head of Drug Discovery, Nicholas Cosford, Ph.D., has been awarded

Read Full Article

UCB receives EU approval for paediatric anti-epileptic drug

    UCB receives EU approval for paediatric anti-epileptic drug

UCB has announced that the European Commission (EC) has approved expanding the use of its anti-epileptic drug (AED) Vimpat (lacosamide) as monotherapy and adjunctive therapy in the treatment of partial-onset

Read Full Article

UK’s NICE approves Roche’s breast cancer drug Kadcyla for routine use

    UK’s NICE approves Roche’s breast cancer drug Kadcyla for routine use

The UK National Institute for Health and Care Excellence (NICE) has granted approval for Roche’s breast cancer drug Kadcyla for routine use within the NHS region. NICE has recommended Kadcyla

Read Full Article

Pfizer’s Meningococcal Group B vaccine, Trumenba, gets approval in Europe

    Pfizer’s Meningococcal Group B vaccine, Trumenba, gets approval in Europe

Pfizer has secured approval the European Commission (EC) for TRUMENBA (Meningococcal Group B Vaccine) for preventing invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) in individuals 10 years

Read Full Article

Aptar Pharma’s electronic lockout device approved by EMA

    Aptar Pharma’s electronic lockout device approved by EMA

The European Medicines Agency (EMA) has approved Aptar Pharma’s integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda Pharmaceuticals International. Aptar Pharma agreed to supply Takeda with its

Read Full Article

Brilique (ticagrelor) new formulation gains European approval

    Brilique (ticagrelor) new formulation gains European approval

The European Commission (EC) has granted marketing authorisation for AstraZeneca’s Brilique (ticagrelor) orodispersible tablets (ODT) as a new method of treatment administration. This decision means that ticagrelor will become the

Read Full Article

EMA approves once-daily therapy for partial-onset epilepsy

    EMA approves once-daily therapy for partial-onset epilepsy

The European Medicines Agency (EMA) has approved Zebinix (eslicarbazepine acetate) for use as once-daily monotherapy to treat adults with newly-diagnosed partial-onset epilepsy. It is already indicated in Europe as an

Read Full Article

MSD probed by UK for blocking Remicade biosimilars

    MSD probed by UK for blocking Remicade biosimilars

The UK government says Merck Sharp & Dohme (MSD) broke competition laws by lowering the price of its Remicade drug as biosimilar rivals came to market. The Competition and Markets

Read Full Article

Biogen Wins Full EC Approval for MS Drug Fampyra

    Biogen Wins Full EC Approval for MS Drug Fampyra

The EC granted full marketing approval for Biogen’s Fampyra® (prolonged-release fampridine) as a treatment to improve walking in people with

Read Full Article

The EMA Grants Priority to an Enzyme to Avoid Liver Transplant Rejection

    The EMA Grants Priority to an Enzyme to Avoid Liver Transplant Rejection

Hansa Medical has accessed the EMA’s priority medicines scheme to accelerate the development of a therapy that broadens the access

Read Full Article

EMA’s CHMP backs Novartis’ Zykadia for first-line use in lung cancer

    EMA’s CHMP backs Novartis’ Zykadia for first-line use in lung cancer

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval to expand the use of

Read Full Article

Pfizer collaboration to reduce injectable contraceptive price

    Pfizer collaboration to reduce injectable contraceptive price

“New innovations in contraceptive technology are needed to expand the number of methods available to women and adolescents so they

Read Full Article

Treatment for hyperkalaemia receives European marketing approval recommendation

    Treatment for hyperkalaemia receives European marketing approval recommendation

Veltassa (patiromer), developed by Relypsa, has received a recommendation for marketing approval from the Committee for Medicinal Products for Human

Read Full Article

A Spanish Biosimilar of Amgen’s Blockbuster gets Ready for EU Approval

    A Spanish Biosimilar of Amgen’s Blockbuster gets Ready for EU Approval

Cinfa Biotech announced trial results for a biosimilar of Amgen’s Neulasta, a multi-billion blockbuster to treat chemotherapy-induced neutropenia. Cinfa Biotech

Read Full Article

Clinigen, Tesaro partner to supply ovarian cancer drug in Europe

    Clinigen, Tesaro partner to supply ovarian cancer drug in Europe

  Clinigen Group’s Idis Managed Access division and Tesaro have partnered to launch a Managed Access Program (also known as

Read Full Article

Pfizer gifts the NHS with breast cancer drug

Pfizer has announced it will provide its breast cancer drug, palbociclib — which has been provisionally rejected by NICE for

Read Full Article

EMA Promotes Understanding and Use of Biosimilars

EMA and the European Commission released a biosimilars information guide for health professionals during the EC’s biosimilars conference. In an

Read Full Article

EU expands use of Janssen’s Darzalex

EU regulators have expanded the scope of Janssen’s Darzalex to include patients with multiple myeloma who have received at least

Read Full Article

Impax Launches Generic Version of Vytorin

Impax Laboratories, Inc., a specialty pharmaceutical company, announced it has received final U.S. Food and Drug Administration (FDA) approval for a

Read Full Article

BTG receives CE mark certification for radiopaque drug-eluting bead

BTG, a global specialist healthcare company, has received Class III CE Mark certification for DC Bead LUMI, the first commercially

Read Full Article

Pfizer’s Xeljanz Authorized for Marketing in the European Union

Xeljanz (tofacitinib citrate) receives marketing authorization in the European Union for the treatment of moderate to severe active rheumatoid arthritis

Read Full Article

EMA Recommends Approval of New Treatment for Brain Cancer

Apeiron Biologics has announced that the EMA’s CHMP has recommended the approval of APN311 for immunotherapy of high risk neuroblastoma.

Read Full Article

A New Parkinson’s Drug from Italy just got FDA Approval!

Newron, an Italian biotech focused on CNS diseases, is on a roll. The latest win? FDA approval of its Parkinson’s

Read Full Article

Debiopharm’s triptorelin 6-month formulation receives EU approval

Debiopharm International, a Swiss-based company, part of Debiopharm Group, announced that triptorelin 6-month formulation (Decapeptyl and Pamorelin 22.5 mg) received

Read Full Article

British Biotech’s Breast Cancer Drug gets FDA Approval for Novartis

Novartis has received FDA approval for Kisqali, a first-line treatment for breast cancer originally developed by the British biotech Astex

Read Full Article

Innovus Receives EU Okay to Market Sensum+ Cream

Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of

Read Full Article

Italy Adopts Gender-Neutral HPV Vaccination Program

Italy adopts gender-neutral HPV vaccination program, citing study by health economics expert from Kingston University London’s Business School. The Italian

Read Full Article

Price drops make more cancer drugs routinely available

The National Institute for Health and Care Excellence (NICE) is half way through a review of drugs approved and still

Read Full Article

Owlstone Medical to provide breath biomarker services for 4D Pharma

Diagnostics company, Owlstone Medical, who is developing a breathalyser for disease has announced it has signed a master service agreement

Read Full Article

Sanofi and AstraZeneca to Collaborate on Antibody for Prevention of Respiratory Illnesses

Sanofi and its vaccines global business unit Sanofi Pasteur announced today an agreement with MedImmune, the global biologics research and development arm of

Read Full Article

Chocolate pill could help cut heart disease risk

The BlowFlow+ pill is the first such product to be made entirely out of chocolate. It’s available in the UK

Read Full Article

EU Approves New Single-Dose Delivery Option for Repatha

Amgen announced that the European Commission (EC) has adopted a decision to change the Repatha (evolocumab) marketing authorization, approving a new

Read Full Article

GSK Reports Positive Results for Once-Daily Inhaled Corticosteroid

GlaxoSmithKline plc and Innoviva, Inc. announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with well-controlled asthma were

Read Full Article

How VAYA Pharma used Facebook ads for its ADHD campaign

The greatest companies in the pharmacology industry are committed to bettering lives through healthcare innovation, and what better way to

Read Full Article

Mundipharma to launch Mabthera biosimilar in EU markets

Mundipharma is gearing up to launch biosimilar Truxima in seven European markets for the treatment of certain cancers and inflammatory

Read Full Article

Sobi enters into new distribution agreement with Valeant for Ammonul

The company has entered into a three-year agreement with Valeant Pharmaceuticals Ireland for the distribution in Europe, the Middle East

Read Full Article

DNA computer brings ‘intelligent drugs’ a step closer

Researchers at Eindhoven University of Technology (TU/e) present a new method that should enable controlled drug delivery into the bloodstream

Read Full Article

Mereo’s brittle bone drug joins EU’s adaptive pathways scheme

UK-based rare and speciality diseases group Mereo BioPharma says its brittle bone disease drug BPS-804 has been accepted to participate

Read Full Article

Swedish Fundraising brings Sickle Cell Disease Drug Closer to the Market

Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition

Read Full Article

Novartis, NHS joint working pact delivers new eye service

People living in Ayrshire and Arran who have some of the most common forms of avoidable sight loss will now

Read Full Article

Upcoming Events

  • November 12, 2018Compamed
  • November 13, 2018Foodpharmatech
  • April 21, 2019Labvolution
AEC v1.0.4

The Magazine

New Subscriber





Subscribe Here



Advertisements